UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000029667
Receipt number R000033901
Scientific Title Retreatment for HIV facial lipoatrophy
Date of disclosure of the study information 2017/10/23
Last modified on 2019/04/26 11:00:17

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Retreatment for HIV facial lipoatrophy

Acronym

Retreatment for HIV facial lipoatrophy

Scientific Title

Retreatment for HIV facial lipoatrophy

Scientific Title:Acronym

Retreatment for HIV facial lipoatrophy

Region

Japan


Condition

Condition

HIV facial lipoatrophy

Classification by specialty

Infectious disease Plastic surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Verification of safety and efficacy of repetitive treatment to HIV facial lipoatrophy after initial plastic surgery

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

quantitative and qualitative evaluation of the facial soft tissue at 48 weeks

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

dermal filler (hyaluronic acid) administeration

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

well controlled HIV infection

Key exclusion criteria

platelet count lower than 50000/mm3
pregnancy

Target sample size

10


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Shinichi Oka

Organization

National Center for Global Health and Medicine

Division name

AIDS Clinical Center

Zip code


Address

1-21-1, Toyama, Shinjuku, Tokyo

TEL

+81-3-3202-7181

Email

oka@acc.ncgm.go.jp


Public contact

Name of contact person

1st name
Middle name
Last name Kunihisa Tsukada

Organization

National Center for Global Health and Medicine

Division name

AIDS Clinical Center

Zip code


Address

1-21-1, Toyama, Shinjuku, Tokyo

TEL

+81-3-3202-7181

Homepage URL


Email

ktsukada@acc.ncgm.go.jp


Sponsor or person

Institute

AIDS Clinical Center, National Center for Global Health and Medicine

Institute

Department

Personal name



Funding Source

Organization

Grant-in-Aid for Scientific Research

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 10 Month 23 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2017 Year 03 Month 24 Day

Date of IRB

2017 Year 03 Month 24 Day

Anticipated trial start date

2017 Year 10 Month 23 Day

Last follow-up date

2019 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 10 Month 23 Day

Last modified on

2019 Year 04 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033901


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name